Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study was designed to determine a cutoff point for identifying insulin resistance from hyperinsulinemic-euglycemic clamp studies performed at 120 mU/m2 ⋅ min in a white population and to generate equations from routinely measured clinic and blood variables for predicting clamp-derived glucose disposal rate (GDR), i.e., insulin sensitivity. RESEARCH DESIGN AND METHODS: We assembled data from hyperinsulinemic-euglycemic clamps (120 mU/m2 ⋅ min insulin dose) performed at the Pennington Biomedical Research Center between 2001 and 2011. Subjects were divided into subjects with diabetes (n = 51) and subjects without diabetes (n = 116) by self-report and/or fasting glucose ≥126 mg/dL. RESULTS: We found that 75% of individuals with a GDR <5.6 mg/kg fat-free mass (FFM) + 17.7 ⋅ min were truly insulin resistant. Cutoff values for GDRs normalized for body weight, body surface area, or FFM were 4.9 mg/kg ⋅ min, 212.2 mg/m2 ⋅ min, and 7.3 mg/kgFFM ⋅ min, respectively. Next, we used classification tree models to predict GDR from routinely measured clinical and biochemical variables. We found that individual insulin resistance could be estimated with good sensitivity (89%) and specificity (67%) from the homeostasis model assessment of insulin resistance (HOMA-IR) >5.9 or 2.8< HOMA-IR <5.9 with HDL <51 mg/dL. CONCLUSIONS: We developed a cutoff for defining insulin resistance from hyperinsulinemic-euglycemic clamps. Moreover, we now provide classification trees for predicting insulin resistance from routinely measured clinical and biochemical markers. These findings extend the clamp from a research tool to providing a clinically meaningful message for participants in research studies, potentially providing greater opportunity for earlier recognition of insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is no consensus on the definition of IR [145,146]”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [145]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,522
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 20,825
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 2×
“The mean rate of exogenous glucose infusion during the last 30 min was defined as the GDR (1).”
BackgroundThe use of the area under the ROC curve in the evaluation of machine learning algorithms
Bradley, A. P. (1997) · Pattern Recognition · doi:10.1016/s0031-3203(96)00142-2 · Cited by 7,217 · cited 2×
“We used a receiver-operating characteristic (ROC) curve, a plot of the sensitivity versus 1 – specificity, to display the trade-off between true positives and false positives across incremental choices of discriminating cutoff points for glucose disposal rate (9,10).”
MethodA formula to estimate the approximate surface area if height and weight be known. 1916.
Bois, D. D., & Bois, E. F. D. (1989) · PubMed · Cited by 5,314
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Assessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Statistics review 13: receiver operating characteristic curves.
Bewick, V., Cheek, L., & Ball, J. (2004) · Critical Care · doi:10.1186/cc3000 · Cited by 818 · cited 1×
“We used a receiver-operating characteristic (ROC) curve, a plot of the sensitivity versus 1 – specificity, to display the trade-off between true positives and false positives across incremental choices of discriminating cutoff points for glucose disposal rate (9,10).”
MethodClark, L. A., & Pregibon, D. (2017) · Statistical Models in S · doi:10.1201/9780203738535-9 · Cited by 560
Cited by
Annals of Agricultural and Environmental Medicine
(2017) · Annals of Agricultural and Environmental Medicine · doi:10.5604/12321966 · Cited by 1,186
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
“5), and their differences are the sensitivity, limitation, and complexity of technical procedures.(35,431) Glucose tolerance test (GTT) is given to determine how quickly exogenous glucose delivered via oral, intraperitoneal, or intravenous administration is cleared from the blood.”
BackgroundSelf-citationLiu, X., Tan, Z., Huang, Y., Zhao, H., Liu, M., Yu, P., Ma, J., Zhao, Y., Zhu, W., & Wang, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01546-0 · Cited by 409
“Furthermore, TyG performed better than HOMA-IR in assessing insulin resistance (sensitivity 89%, specificity 67%) [47].”
MethodSon, D.-H., Lee, H. S., Lee, Y.-J., Lee, J.-H., & Han, J.-H. (2022) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.11.017 · Cited by 394
Measuring and estimating insulin resistance in clinical and research settings
Gastaldelli, A. (2022) · Obesity · doi:10.1002/oby.23503 · Cited by 244
“8 when high-density lipoprotein (HDL) < 51 mg/dL [11].”
Metadata
- Authors
- Tam, C. S., Xie, W., Johnson, W. D., Cefalu, W. T., Redman, L. M., & Ravussin, E.
- Affiliations
- Pennington Biomedical Research Center (US)
- Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-06-12
- Volume
- 35
- Issue
- 7
- Pages
- 1605-1610
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3379600
- OpenAlex
- W2144789811
- Semantic Scholar
- 305e825690957f04df3471db275d0357f65dc523
- Cited by
- 364
- References
- 17
- Citations by year
- 2026: 35 · 2025: 51 · 2024: 51 · 2023: 43 · 2022: 37 · 2021: 25 · 2020: 23 · 2019: 17 · 2018: 17 · 2017: 6 · 2016: 12 · 2015: 19 · 2014: 13 · 2013: 11 · 2012: 4
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK060412, U01DK094418, P30DK072476)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R00HD060762)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin resistance, hyperinsulinemic-euglycemic clamp, glucose disposal rate, insulin sensitivity, cut-off values, HOMA-IR, HDL cholesterol, classification trees, diabetes mellitus, fat-free mass
- MeSH terms
- Adult, Aged, Decision Trees, Humans, Insulin, Insulin Resistance, Middle Aged, Models, Biological, Reference Values, Glucose Clamp Technique, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps. https://app.cochat.ai/papers/10.2337/dc11-2339
- The paper
- Tam, C. S., Xie, W., Johnson, W. D., Cefalu, W. T., Redman, L. M., & Ravussin, E. (2012). Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps. Diabetes Care. https://doi.org/10.2337/dc11-2339
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.